TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <100nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <500nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Centaurus Biopharma
US Patent
Centaurus Biopharma
US Patent
Affinity DataIC50: <1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds were diluted from DMSO stocks into 1× buffer (20 mM MOPS, PH 7.4, 5 mM MgCl2, 0.5 mM MnCl2, 100 uM Sodium Orthovanadate, 0.01% Triton X-100...More data for this Ligand-Target Pair